Skip to main content

Global Closed System Drug Transfer Device (CSTD) Market Scope, Growth Drivers, Key Players Future industry Trends and Outlook 2025

 Global Closed System Drug Transfer Device (CSTD) Market Research Report: by Type (Barrier-Type, Filtration-Type), by Delivery (Closed Bag/Line Access Devices, Closed Vial Access Devices, Closed Syringe Safety Devices), by End-user - Forecast till 2025

Market Highlights

The market is driven by the prevalence of cancer cases globally. According to the Canadian Cancer Society in 2017, nearly 206, 200 instances were registered with 80,800 dying from the disease. CSTDs are required for protecting hospital staff from hazardous drugs and ensuring their safety. Furthermore, safety guidelines outlined by regulatory bodies for safe handling practices at hospitals and clinics is predicted to augur well for the closed system drug transfer device (CSTD) market.

Avail a Free Sample@ https://www.marketresearchfuture.com/sample_request/7733

The global closed system drug transfer device (CSTD) market size is poised to expand at 19.10% CAGR over the forecast period (2018-2025).

Segmentation Analysis

The closed system drug transfer device (CSTD) market is segmented by type, delivery, and end-user.

By type, barrier-type was the largest shareholder in 2017, while the filtration-type held stood second in the global market. This can be attributed to the use of filtration systems for segregating hazardous materials to ensure the safety of hospital staff. By modes of delivery, closed bag/line access devices accounted for the largest share in the CSTD market (2017). Among end-users, specialty centers held 70.92% market share in 2017. This can be linked to high use of chemotherapy drugs by oncology professionals to treat patients suffering from cancer.

Regional Analysis

Geographically, the closed system drug transfer device (CSTD) market covers the upcoming trends in Europe, Asia Pacific (APAC), Americas, and the Middle East & Africa (MEA).

The Americas accounted for the largest market share in 2017 and was followed by Europe, APAC and MEA.

Europe has assumed the second position after the Americas mainly due to the sophisticated healthcare industry. Awareness of the adverse effects of drug exposure which may cause infertility coupled with availability of CSTD products for hospitals can evoke high market demand during the forecast period.

The MEA region is projected to experience a sluggish growth rate due to the underdeveloped healthcare sector and low adoption rate of latest technologies.

Competitive Analysis

Key players in the closed system drug transfer device (CSTD) market include Teva Pharmaceutical Industries Ltd. (Israel), Becton, Dickinson and Company (U.S.), Corvida Medical (U.S.), ICU Medical Inc. (U.S.), Yukon Medical (U.S.), and Equashield LLC (U.S.).

Access Report Details @  https://www.marketresearchfuture.com/reports/closed-system-drug-transfer-device-market-7733

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Comments

Post a Comment

Popular posts from this blog

Immunoassay Analyzers Market By Methods, Technologies, Clinical Review and Industry Outlook

  Immunoassay Analyzers Market  Research Report By Instruments (Immunofluorescence, Chemiluminescence, ELISA, Radioimmunoassay), Application (Infectious Diseases, Autoimmune Diseases, AIDS), End Users (Hospitals)- Global Forecast till 2023 Market Scenario Immunoassay analyzer is a device which measures the presence and concentration of proteins in analyte samples. These instruments are mostly used by pharmaceutical & biotechnological companies, laboratories, and research institutes. The global immunoassay analyzer market is driven by an increasing number of pharmaceutical and biotechnological companies, rising prevalence of different life-threatening diseases, and government’s initiatives for research & development activities. Furthermore, rapid development in diagnostic medical devices, increasing need for better drug treatment, and the increasing geriatric population had also fueled the market’s growth. On the other hand, high cost of instruments and poor reimburseme...
Post a Comment
Read more

Laser Therapy Market Top Company Profiles, Latest Technology, Global Size, Industry Trends

  Laser Therapy Market  Research Report, By Type (Diode Lasers, Solid State Lasers, Gas Lasers, Dye Lasers, and others), By Application (Dermatology and Aesthetics, Surgery, Dental, Urology, Ophthalmology, and others) - Global Forecast from 2017 to 2023 Market Overview: Market Research Future (MRFR) anticipates strong CAGR of 9.2% in the global laser therapy market over the forecast period of 2017-2023. The expansion of the global laser therapy is the result of various market dynamics, out of which, the surging prevalence of diseases such as cataract and arthritis bears profound weightage. Laser therapy is the standard line of treatment in cases of cataract. Laser-based ophthalmology is highly preferred over other methods of treatment. YAG LASER, excimer LASER, femtosecond LASER, and others are the most commonly used lasers in ophthalmology. The widespread prevalence of cataract, as well as arthritis, promote the growth of the global laser therapy market. Expanding base of old...
Post a Comment
Read more

Nonallergic Rhinitis Market Data, Technology Treatment and Diagnosis Management Overview

  Nonallergic Rhinitis Market  Share, Growth And Trends Analysis By Diagnosis (Physical Examination, Allergy Testing, And Imaging Test), By Treatment (Nasal Sprays, Nsaids), And By End User (Hospitals &, Clinics, Research Centers) - Global Forecast Till 2023 Market Highlights Nonallergic rhinitis, also known as vasomotor rhinitis is a medical condition that refers to a set of symptoms that resemble nasal allergies and hayfever (allergic rhinitis) occurring without a known cause. Some of the symptoms of non-allergic rhinitis include Postnasal drip, Runny nose, Sneezing, and Stuffy nose among others. Some patients with nonallergic rhinitis may even develop allergies and asthma eventually, hence treating the condition well in time becomes essential. Industry, Innovation & Related News November 08, 2018 – AstraZeneca Plc. (the UK), a multinational pharmaceutical and biopharmaceutical company announced the sale of its rights for asthma drug Alvesco (ciclesonide), nasal spra...
Post a Comment
Read more